501082-80-0

Basic information

• Product Name: L-Leucinamide, O-[(2,6-dichlorophenyl)methyl]-N-[(1,1-dimethylethoxy)carbonyl]-L-tyrosyl glycylglycyl-L-phenylalanyl-
• CAS NO: 501082-80-0
• Molecular Formula: C40H50Cl2N6O8
• Molecular Weight: 813.778
• Mol File: 501082-80-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: L-Leucinamide, O-[(2,6-dichlorophenyl)methyl]-N-[(1,1-dimethylethoxy)carbonyl]-L-tyrosyl glycylglycyl-L-phenylalanyl-(CAS DataBase Reference)
• NIST Chemistry Reference: L-Leucinamide, O-[(2,6-dichlorophenyl)methyl]-N-[(1,1-dimethylethoxy)carbonyl]-L-tyrosyl glycylglycyl-L-phenylalanyl-(501082-80-0)
• EPA Substance Registry System: L-Leucinamide, O-[(2,6-dichlorophenyl)methyl]-N-[(1,1-dimethylethoxy)carbonyl]-L-tyrosyl glycylglycyl-L-phenylalanyl-(501082-80-0)

Safety Data

• Hazardous Substances Data: 501082-80-0(Hazardous Substances Data)

Upstream product

• 106624-70-8 methyl (2S)-2-[[2-(t-butoxycarbonylamino)acetyl]amino]-3-phenylpropanoate 
• 19240-24-5 N--L-3-phenylalanine methyl ester hydrochloride 
• 61131-29-1 N-glycyl>-L-3-phenylalanine methyl ester hydrochloride 
• 63631-32-3 (S)-methyl 12-benzyl-2,2-dimethyl-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oate 
• 501082-71-9 Boc-Tyr(2,6-Cl₂Bzl)-Gly-Gly-Phe-OMe 
• 687-51-4 H-L-Leu-NH₂ 
• 501082-72-0 Boc-Tyr(2,6-Cl₂Bzl)-Gly-Gly-Phe-OH 

Downstream Products

• 501083-17-6 estrone-3-O-CH₂CO-Tyr(2,6-dichlorobenzyl)-Gly-Gly-Phe-Leu-NH₂ 
• 501082-99-1 C₅₇H₆₈Cl₂N₆O₁₀ 
• 501083-26-7 C₅₅H₆₆Cl₂N₆O₉ 
• 521060-85-5 C₅₅H₆₆Cl₂N₆O₉ 
• 183670-74-8 H-Tyr(DCB)-Gly-Gly-Phe-Leu-NH₂ 
• 60117-24-0 H-Tyr-Gly-Gly-Phe-Leu-NH₂ 

Relevant articles and documents

Studies on the synthesis and anti-Osteoporosis of estrogen-GHRPs linkers.

The linkers of estrogen-GHRPs were prepared by the combination of estradiol, estrone, TyrGlyGlyPheLeuOH, and TyrGlyGlyPheLeuOH. Their anti-osteoporosis effect was evaluated by analyzing the data, for instance the weight of the body, femur, femur ash, the content of calcium and phosphor in the femur, the content of calcium and ALP activity in the serum, obtained from the corresponding bioassay in vivo. The results indicated that the anti-osteoporosis potency for estradiol, estrone, TyrGlyGlyPheLeuOH and TyrGlyGlyPheLeuNH(2) may be totally enhanced each other via the corresponding linkers.